Immune Biosolutions
PrivateLast Round
Series A
Mar 16, 2021
Total Funding Raised
$18.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Immune Biosolutions is a biotechnology company that develops clinical-grade antibodies for therapeutic and diagnostic applications in areas such as infectious diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immune Biosolutions Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Immune Biosolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 16, 2021 | ||||
| Debt | May 31, 2019 | ||||
| Grant | Jun 12, 2018 | ||||
| Seed | Apr 19, 2017 |
Key People
Founding team and executive leadership
Immune Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Society | Grant |
| Consortium Québécois sur la découverte du médicament | Grant |
| Canada Economic Development for Quebec Regions | Debt |
| AmorChem | Series A, Seed |
| Government of Canada | Series A |
| Mitacs | Grant |
| Accélérateur de création d'entreprises technologiques | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased by 33% MoM.
- Nov 7, 2025
Monthly visitors increased 221% MoM.
Immune Biosolutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immune Biosolutions's valuation, stock price, and market status.